The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index; 13 of the 27 sources its claims cite were checked for support.
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Open accessAbstract
Here we show that nicotinamide riboside kinase 1 (NRK1) is necessary and rate-limiting for the use of exogenous NR and NMN for NAD+ synthesis. Using stable isotope-labelled compounds, we confirm NMN is metabolized extracellularly to NR that is then taken up by the cell and converted into NAD+.
Overview
CoChat Summary
## TL;DR
NRK1 is the key rate-limiting enzyme that mammalian cells and liver require to convert exogenous nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) into NAD+. The paper shows that NMN is first dephosphorylated extracellularly to NR, which is then taken up and used for NAD+ synthesis.
## Key findings
- In NIH/3T3 cells, overexpression of active NRK1 or NRK2 converted NR-nonresponsive cells into NR-responsive cells, producing about a 4-fold increase in NAD+; catalytically inactive NRK1-D36A and NRK2-D35A did not.
- In F3T3-NRK1 cells, NR increased NAD+ at concentrations as low as 100 μM, with maximal effects at about 1 mM; NMN increased NAD+ only in NRK1-overexpressing cells and less potently than NR, while NAM worked regardless of NRK1.
- In primary hepatocytes from NRK1KO mice, NR and NMN failed to increase NAD+, whereas NA and NAM still increased NAD+ normally.
- In vivo, 500 mg kg−1 intraperitoneal NR raised liver NAD+ by about 220% in wild-type mice; NMN and NAM raised it by about 170%, and NR/NMN responses were significantly blunted in NRK1KO mice, though about 60% of the NR and NMN effect remained.
## Methods
- The study used gain- and loss-of-function models: transient and stable NRK1/NRK2 overexpression in cell lines, siRNA knockdown of Nmrk1 in AML12 hepatocytes, and a constitutive Nmrk1 knockout mouse.
- NAD+ precursor metabolism was tested in cultured cells, primary hepatocytes, primary brown adipocytes, and mice using NR, NMN, NAM, and NA treatments, plus isotope-labeled compounds for flux analysis.
- Main analyses included NAD+ quantification by assay, targeted LC-MS/LC-QqQ MS metabolomics, western blotting, and qPCR; statistical testing used t-tests or one-way ANOVA with Bonferroni post-test.
## Limitations
- The paper states that data are available only upon request, which limits immediate reproducibility access.
- The text makes evident that several mechanistic claims rely on high-dose precursor injections in mice (e.g., 500 mg kg−1 and 50 mg kg−1), so some in vivo effects may not reflect physiological exposure; this is evident from the text.
- The paper itself notes that future work is needed to better characterize circulating NAD+, NMN, and NR and to optimize organ-targeted formulations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Extracellular NMN dephosphorylates to NR. HepG2 cells were treated with [18O]-labelled NR (a,b) or NMN (c,d). Intracellular enrichment of labelled compounds (a,c) and presence of labelled compounds in the media of treated cells (b,d). Results shown are mean±s.e.m. (n=3).](https://figures.cochat.ai/paper-figures/57e8a39cf3da45969cbff31a92059db8/nrk1-controls-nicotinamide-mononucleotide-and-nicotinamide-riboside-metabolism-figure-4.jpg)

![Figure 6 Extracellular conversion of NMN to NR by hepatocytes. (a) Primary hepatocytes were isolated from 10 to 15 weeks old WT mice. Cells were treated with 2 μM FK866 and ±2 mM CMP for 1 h. Then, 0.5 mM NR or NMN was added and NAD+ was measured after 2 h. (b,c) WT (b) and NRK1KO (c) hepatocytes were treated with [2H]-[13C]-double labelled NR or NMN. Intracellular enrichment of labelled compounds. Results shown are mean±s.e.m., **P<0.01 versus ctrl by two-sided unpaired T-test (n=3).](https://figures.cochat.ai/paper-figures/d72a2197ccbc48f5bcf199a67d302e52/nrk1-controls-nicotinamide-mononucleotide-and-nicotinamide-riboside-metabolism-figure-6.jpg)


Verification
Claims the paper makes
12 Valid · 1 Not valid · 12 Not checked · 97 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Whereas NMN concentration has been reported to reach around 50 μM in plasma14, our study and others13 have failed to detect comparable levels of circulating NMN.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Not checked — no full text of the sourcecites [14] Revollo, J. R. et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6, 363–375 (2007). source
- Supportedcites [13] Hara, N., Yamada, K., Shibata, T., Osago, H. & Tsuchiya, M. Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma. PLoS ONE 6, e22781 (2011). source
The Results section reports that NMN was not detected in freshly prepared mouse plasma by LC/MS/MS, with a detection limit of 50 nM—far below the approximately 50 µM level mentioned in the citing sentence. The Discussion likewise contrasts this nondetection with earlier reports of high plasma NMN concentrations. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In line with this, CD73 silencing blocks the use of NMN as an extracellular NAD+ precursor17.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Partly supportedcites [17] Sociali, G. et al. Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model. Oncotarget 7, 2968–2984 (2015). sourceExperimental — accuracy not yet measured
The Results section (Figure 2D) reports that CD73 silencing reduced by 70% the ability of FK866-treated OVCAR-3 cells to generate intracellular NAD+ from extracellular NMN. This supports impaired use of NMN, but not the claim that silencing completely blocks it. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, the induction of NRK2 in response to cellular damage or stress32 suggests the existence of a demand for circulating NR.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Supportedcites [32] Sasaki, Y., Araki, T. & Milbrandt, J. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J. Neurosci. 26, 8484–8491 (2006). source
The Results section, “Expression of enzymes involved in NAD biosynthesis is induced in response to neuronal injury” (page not provided), reports that Nrk2 expression rose more than 20-fold after axotomy. The Discussion interprets this as part of the neuronal response to stress. The sentence’s suggestion of demand for circulating NR is the citing authors’ inference, not a finding it attributes to this source. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This experiment, conducted in parallel with a human clinical trial at the same effective dose of NR, showed that NR produces the greatest rise in liver NAD+ synthesis, followed by NAM and NA24.”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Discussion
What the sources say
- Supportedcites [24] Trammell, S. A. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016). source
The Results section ('NR is the superior hepatic NAD+ precursor vitamin'; page not supplied) says the mouse dose was chosen to be comparable, after body-size adjustment, to an effective human NR dose, and that mice received NR or equimolar NAM and NA. The Discussion (page not supplied) ranks their effects on mouse liver NAD+ as NR, then NAM, then NA. The paper also reports a human clinical trial; it does not establish that the mouse experiment and trial ran at the same time. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, WT mice and NRK1/NRK2DKO displayed comparable increases in NAD+ levels in skeletal muscle after intraperitoneal NR and NMN administration (Supplementary Fig. 3d).”
§ NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells > Results > NRK1KO mice are deficient in NR and NMN utilization in vivo
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 122 claims and every source verdict.
- Probably not a substantial claim. 25
- It may state two separate claims as one. 49
- Borderline: one of the tests for a substantial claim is unclear. 1
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Experimental evidence suggests that blood NA and NAM are able to cross the plasma membrane, while blood NAD+ cannot be taken up by cells directly but needs to be converted to smaller uncharged molecules to enter the cells (Hara et al., 2007; Ratajczak et al., 2016).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Ratajczak et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a previous study, the deficiency of NRK1, which phosphorylates NR to NMN, diminished the increase of NAD+ levels in the liver after oral NMN administration, suggesting that NMN was converted to NR before absorption (11).”
From Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD + synthesis via enterohepatic circulation (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Meanwhile, NR is converted to NMN by NR kinase (NRK), thereby bypassing the NAMPT-mediated step (11, 12).”
From Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD + synthesis via enterohepatic circulation (2025) · cites this paper as [11]
In the citing paper
“Additionally, nicotinamide riboside (NR) integrates in this pathway via the conversion of NR into NMN by nicotinamide riboside kinase 1 (NRK1) or NRK2 (Bieganowski and Brenner, 2004; Ratajczak et al., 2016).”
From NAD+ in Brain Aging and Neurodegenerative Disorders (2019) · cites this paper as Ratajczak et al., 2016
Citations
Cites
HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS
Berry, M. N., & Friend, D. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.43.3.506 · Cited by 4,424
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085 · cited 1×
“Importantly, sirtuin activation has been associated with an improvement in metabolic efficiency and healthspan in mammals 4,5 .”
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008
Self-citationCantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Self-citationGomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255
Self-citationCantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Self-citationMouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210
Self-citationNAD+ metabolism in health and disease
Belenky, P., Bogan, K. L., & Brenner, C. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.11.006 · Cited by 981
Self-citationNampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911
Camacho-Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.006 · Cited by 901 · cited 1×
“Importantly, NRK1 overexpression did not affect the expression of NADases, such as CD38 and its homolog CD157, or the CD73 nucleotidase, all of which have been reported to influence NMN conversion to NR 15,27 (Supplementary Fig.”
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899
Self-citationBieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
Self-citationNicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae
Anderson, R. M., Bitterman, K. J., Wood, J. G., Medvedik, O., & Sinclair, D. A. (2003) · Nature · doi:10.1038/nature01578 · Cited by 736
Bogan, K. L., & Brenner, C. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155443 · Cited by 707
Self-citationNicotinamide riboside is uniquely and orally bioavailable in mice and humans
Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C. (2016) · Nature Communications · doi:10.1038/ncomms12948 · Cited by 697 · cited 4×
“NR has recently been shown to be the favoured orally available hepatic precursor to NAD þ in mice and to safely boost human NAD þ metabolism in single oral doses 24 .”
InfluentialSelf-citationMolecular Identification of High and Low Affinity Receptors for Nicotinic Acid
Wise, A., Foord, S. M., Fraser, N. J., Barnes, A. A., Elshourbagy, N., Eilert, M., Ignar, D. M., Murdock, P. R., Steplewski, K., Green, A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210695200 · Cited by 539
Belenky, P., Racette, F. G., Bogan, K. L., McClure, J. M., Smith, J. S., & Brenner, C. (2007) · Cell · doi:10.1016/j.cell.2007.03.024 · Cited by 411
Self-citationGariani, K., Menzies, K. J., Ryu, D., Wegner, C. J., Wang, X., Ropelle, E. R., Moullan, N., Zhang, H., Perino, A., Lemos, V., et al. (2016) · Hepatology · doi:10.1002/hep.28245 · Cited by 368
Self-citationPathways and Subcellular Compartmentation of NAD Biosynthesis in Human Cells
Nikiforov, A., Dölle, C., Niere, M., & Ziegler, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213298 · Cited by 326 · cited 5×
“Whereas CMP did not affect NR action, it fully inhibited the increase in NAD þ on NMN supplementation, showing the necessity of NMN dephosphorylation to NR by an enzyme that is competitively inhibited by CMP (Fig.”
InfluentialYamamoto, T., Byun, J., Zhai, P., Ikeda, Y., Oka, S., & Sadoshima, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098972 · Cited by 305
Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
Trammell, S. A. J., Weidemann, B. J., Chadda, A., Yorek, M. S., Holmes, A., Coppey, L. J., Obrosov, A., Kardon, R. H., Yorek, M. A., & Brenner, C. (2016) · Scientific Reports · doi:10.1038/srep26933 · Cited by 301 · cited 3×
“NR supplementation increases lifespan in yeast, Caenorhabditis elegans and mice 20–22 and improves high-fat diet-induced metabolic complications in mice 19,23 .”
InfluentialSelf-citationBrown, K. D., Maqsood, S., Huang, J.-Y., Pan, Y., Harkcom, W., Li, W., Sauve, A., Verdin, E., & Jaffrey, S. R. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.11.003 · Cited by 277
Sasaki, Y., Araki, T., & Milbrandt, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2320-06.2006 · Cited by 269 · cited 1×
“In addition, the induction of NRK2 in response to cellular damage or stress 32 suggests the existence of a demand for circulating NR.”
ARTD1/PARP1 Negatively Regulates Glycolysis by Inhibiting Hexokinase 1 Independent of NAD+ Depletion
Fouquerel, E., Goellner, E. M., Yu, Z., Gagné, J.-P., Barbi de Moura, M., Feinstein, T., Wheeler, D., Redpath, P., Li, J., Romero, G., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.036 · Cited by 212
Self-citationTARGETED, LCMS-BASED METABOLOMICS FOR QUANTITATIVE MEASUREMENT OF NAD+ METABOLITES
Trammell, S. A., & Brenner, C. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201301012 · Cited by 192
Self-citationNicotinamide Riboside Kinase Structures Reveal New Pathways to NAD+
Tempel, W., Rabeh, W. M., Bogan, K. L., Belenky, P., Wojcik, M., Seidle, H. F., Nedyalkova, L., Yang, T., Sauve, A. A., Park, H.-W., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050263 · Cited by 162
Self-citationGrozio, A., Sociali, G., Sturla, L., Caffa, I., Soncini, D., Salis, A., Raffaelli, N., De Flora, A., Nencioni, A., & Bruzzone, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470435 · Cited by 158
Yang, T., Chan, N. Y., & Sauve, A. A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701001c · Cited by 116
Hara, N., Yamada, K., Shibata, T., Osago, H., & Tsuchiya, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022781 · Cited by 116
Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk
Trammell, S. A., Yu, L., Redpath, P., Migaud, M. E., & Brenner, C. (2016) · The Journal of Nutrition · doi:10.3945/jn.116.230078 · Cited by 112
Self-citationHövener, J., Schwaderlapp, N., Borowiak, R., Lickert, T., Duckett, S. B., Mewis, R. E., Adams, R. W., Burns, M. J., Highton, L. A. R., Green, G. G. R., et al. (2014) · Analytical Chemistry · doi:10.1021/ac403653q · Cited by 111
Nicotinamide Riboside and Nicotinic Acid Riboside Salvage in Fungi and Mammals
Belenky, P., Christensen, K. C., Gazzaniga, F., Pletnev, A. A., & Brenner, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807976200 · Cited by 95
Self-citationSIRT1 enhances glucose tolerance by potentiating brown adipose tissue function
Boutant, M., Joffraud, M., Kulkarni, S. S., García-Casarrubios, E., García-Rovés, P. M., Ratajczak, J., Fernández-Marcos, P. J., Valverde, Á. M., Serrano, M., & Cantó, C. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.12.008 · Cited by 94
Self-citationGeneration, Release, and Uptake of the NAD Precursor Nicotinic Acid Riboside by Human Cells
Kulikova, V., Shabalin, K., Nerinovski, K., Dölle, C., Niere, M., Yakimov, A., Redpath, P., Khodorkovskiy, M., Migaud, M. E., Ziegler, M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.664458 · Cited by 84 · cited 1×
“Interestingly, it was recently shown that human cytosolic 5 0 -nucleotidases can catalyse the conversion of NMN into NR inside the cell and that at least some cells are able to release nucleoside precursors of NAD þ synthesis for other cells 36 , which also suggests that NR is in circulation.”
Self-citationSaccharomyces cerevisiae YOR071C Encodes the High Affinity Nicotinamide Riboside Transporter Nrt1
Belenky, P. A., Moga, T. G., & Brenner, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800021200 · Cited by 78
Self-citationLu, S.-P., Kato, M., & Lin, S.-J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.004010 · Cited by 75 · cited 1×
“…to sirtuin activation, as both compounds led to higher sirtuin activities from yeast to mammals 9,19–21, 23, 28, While extracellular dephosphorylation of NMN into NR is necessary for its utilization in yeast 34 , the means by which NMN is utilized by mammalian cells remained controversial.”
A chemical synthesis of nicotinamide adenine dinucleotide (NAD+)
Lee, J., Churchil, H., Choi, W., et al. (1999) · Chemical Communications · doi:10.1039/a809930h · Cited by 73
Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model
Sociali, G., Raffaghello, L., Magnone, M., Zamporlini, F., Emionite, L., Sturla, L., Bianchi, G., Vigliarolo, T., Nahimana, A., Nencioni, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6502 · Cited by 70 · cited 5×
“In line with this, CD73 silencing blocks the use of NMN as an extracellular NAD þ precursor 17 .”
InfluentialNicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats
Li, D., Tian, Y., Guo, J., Sun, W., Lun, Y., Guo, M. H., Luo, N., Cao, Y. Q., Cao, J.-M., Gong, X., et al. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513001815 · Cited by 66
Partial Reversal of Skeletal Muscle Aging by Restoration of Normal NAD + Levels
Mendelsohn, A. R., & Larrick, J. W. (2014) · Rejuvenation Research · doi:10.1089/rej.2014.1546 · Cited by 53
Continuous Re‐hyperpolarization of Nuclear Spins Using Parahydrogen: Theory and Experiment
Hövener, J., Knecht, S., Schwaderlapp, N., et al. (2014) · ChemPhysChem · doi:10.1002/cphc.201402177 · Cited by 50 · cited 2×
“Labelled D -ribofuranose 1,2-2 H,3,5-tetraacetate (precursor to Vorbru¨ggen glycosylation) was synthesized from D-[2-2 H]-ribose (purchased from Omicron Biochemicals) according to Begley et al. 41 Double labelled 13 C-2 H nicotinamide riboside was synthesized from 13 C-nicotinamide and D -ribofuranose 1,2-2 H,3,5-tetr…”
Utilization and Metabolism of NAD by Haemophilus parainfluenzae
Cynamon, M. H., Sorg, T. B., & Patapow, A. (1988) · Microbiology · doi:10.1099/00221287-134-10-2789 · Cited by 32
Characterization of NAD salvage pathways and their role in virulence in Streptococcus pneumoniae
Johnson, M. D. L., Dao, T. H., Echlin, H., & Rosch, J. W. (2015) · Microbiology · doi:10.1099/mic.0.000164 · Cited by 27 · cited 1×
“Finally, the presence of NR in bodily fluids is also supported by the fact that several bacteria affecting humans, such as Haemophilus influenza and Streptococcus pneumoniae rely on exogenous NR to support NAD þ synthesis and life 37,38 .”
Cited by
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism
Xiao, W., Wang, R.-S., Handy, D. E., & Loscalzo, J. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7216 · Cited by 1,061
“In mice, injection of NR augmented NAD levels in the muscle, liver, brain, and brown adipose tissue, an effect that was abrogated in NRK1 knockout mice (108).”
BackgroundNAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.002 · Cited by 1,061
“…2016 C57BL/6NTac wild-type and Nrk1 KO, or Nrk1/2 double KO mice male 500 mg/kg, 50 mg/kg (IP) 1 hr some degradation of NR to NAM detectable in plasma Ratajczak et al., 2016 C57BL/6JRcc mice fed a medium-/highfat diet male 5–900 ppm (diet) 30 ppm for 4 weeks, then stratified to test groups for…”
InfluentialNAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
“NR, which can cross the cell membrane through a dypiridamole-inhibitable nucleoside transporter, is preferentially used by muscle to synthesize NAD.(98) Accordingly, the NR-using enzyme, NRK2, is usually specifically expressed in the skeletal muscle.”
BackgroundTherapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
“In rodents, NR is more efficient in boosting NAD+ than NA and NAM (Trammell et al., 2016a), possibly due to increased uptake (Imai, 2009; Imai and Guarente, 2014; Ratajczak et al., 2016; Revollo et al., 2007a).”
Influential
Metadata
- Authors
- Ratajczak, J., Joffraud, M., Trammell, S. A. J., Ras, R., Canela, N., Boutant, M., Kulkarni, S. S., Rodrigues, M., Redpath, P., Migaud, M. E., Auwerx, J., Yanes, O., Brenner, C., & Cantó, C.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- University of Iowa (US)
- Centre for Omic Sciences (ES)
- Queen's University Belfast (GB)
- Corresponding author
- Brenner, Charles
- Cantó, Carles
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-11
- Volume
- 7
- Issue
- 1
- Pages
- 13103-13103
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5476803
- OpenAlex
- W2531686927
- Cited by
- 378
- References
- 46
- Citations by year
- 2026: 34 · 2025: 35 · 2024: 48 · 2023: 46 · 2022: 38 · 2021: 40 · 2020: 31 · 2019: 43 · 2018: 28 · 2017: 31 · 2016: 2
- FWCI
- 19.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Roy J. Carver Charitable Trust
- École Polytechnique Fédérale de Lausanne
- National Institutes of Health
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council (BB/N001842/1)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Heart, Lung, and Blood Institute (R01HL108379)
- National Institute of General Medical Sciences (T32GM008629)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Keywords
- nicotinamide mononucleotide, nicotinamide riboside, NAD+ synthesis, NAD+ precursors, sirtuins, poly(ADP-ribose) polymerase, NAD+ supplementation
- MeSH terms
- Animals, Humans, Injections, Intraperitoneal, Mammals, NAD, Niacinamide, Nicotinamide Mononucleotide, Pyridinium Compounds, Phosphotransferases (Alcohol Group Acceptor), Mice, Knockout, Hepatocytes, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.